,title,geo_accession,status,submission_date,last_update_date,type,channel_count,source_name_ch1,organism_ch1,characteristics_ch1,characteristics_ch1.1,characteristics_ch1.2,characteristics_ch1.3,characteristics_ch1.4,characteristics_ch1.5,treatment_protocol_ch1,growth_protocol_ch1,molecule_ch1,extract_protocol_ch1,label_ch1,label_protocol_ch1,taxid_ch1,hyb_protocol,scan_protocol,description,data_processing,platform_id,contact_name,contact_email,contact_institute,contact_address,contact_city,contact_zip/postal_code,contact_country,supplementary_file,data_row_count,age:ch1,disease state:ch1,hbv status:ch1,individual id:ch1,Sex:ch1,tissue:ch1 GSM3428716,Tumor (HCC 17T),GSM3428716,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 17,disease state: HCC,tissue: Tumor sample,age: M,Sex: 72,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428716/suppl/GSM3428716_HCC_17T.CEL.gz,54675,M,HCC,Positive,17,72,Tumor sample GSM3428717,Tumor (HCC 32T),GSM3428717,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 32,disease state: HCC,tissue: Tumor sample,age: M,Sex: 39,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428717/suppl/GSM3428717_HCC_32T.CEL.gz,54675,M,HCC,Positive,32,39,Tumor sample GSM3428718,Tumor (HCC 37T),GSM3428718,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 37,disease state: HCC,tissue: Tumor sample,age: M,Sex: 63,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428718/suppl/GSM3428718_HCC_37T.CEL.gz,54675,M,HCC,Positive,37,63,Tumor sample GSM3428719,Tumor (HCC 38T),GSM3428719,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 38,disease state: HCC,tissue: Tumor sample,age: M,Sex: 44,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428719/suppl/GSM3428719_HCC_38T.CEL.gz,54675,M,HCC,Positive,38,44,Tumor sample GSM3428720,Tumor (HCC 40T),GSM3428720,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 40,disease state: HCC,tissue: Tumor sample,age: M,Sex: 43,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428720/suppl/GSM3428720_HCC_40T.CEL.gz,54675,M,HCC,Positive,40,43,Tumor sample GSM3428721,Tumor (HCC 42T),GSM3428721,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 42,disease state: HCC,tissue: Tumor sample,age: M,Sex: 38,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428721/suppl/GSM3428721_HCC_42T.CEL.gz,54675,M,HCC,Positive,42,38,Tumor sample GSM3428722,Tumor (HCC 43T),GSM3428722,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 43,disease state: HCC,tissue: Tumor sample,age: M,Sex: 47,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428722/suppl/GSM3428722_HCC_43T.CEL.gz,54675,M,HCC,Positive,43,47,Tumor sample GSM3428723,Tumor (HCC 44T),GSM3428723,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 44,disease state: HCC,tissue: Tumor sample,age: F,Sex: 74,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428723/suppl/GSM3428723_HCC_44T.CEL.gz,54675,F,HCC,Positive,44,74,Tumor sample GSM3428724,Tumor (HCC 45T),GSM3428724,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 45,disease state: HCC,tissue: Tumor sample,age: M,Sex: 75,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428724/suppl/GSM3428724_HCC_45T.CEL.gz,54675,M,HCC,Positive,45,75,Tumor sample GSM3428725,Tumor (HCC 53T),GSM3428725,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 53,disease state: HCC,tissue: Tumor sample,age: F,Sex: 58,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428725/suppl/GSM3428725_HCC_53T.CEL.gz,54675,F,HCC,Positive,53,58,Tumor sample GSM3428726,Tumor (HCC 54T),GSM3428726,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 54,disease state: HCC,tissue: Tumor sample,age: M,Sex: 55,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428726/suppl/GSM3428726_HCC_54T.CEL.gz,54675,M,HCC,Positive,54,55,Tumor sample GSM3428727,Tumor (HCC 55T),GSM3428727,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 55,disease state: HCC,tissue: Tumor sample,age: M,Sex: 51,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428727/suppl/GSM3428727_HCC_55T.CEL.gz,54675,M,HCC,Positive,55,51,Tumor sample GSM3428728,Tumor (HCC 56T),GSM3428728,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 56,disease state: HCC,tissue: Tumor sample,age: M,Sex: 51,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428728/suppl/GSM3428728_HCC_56T.CEL.gz,54675,M,HCC,Positive,56,51,Tumor sample GSM3428729,Tumor (HCC 60T),GSM3428729,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 60,disease state: HCC,tissue: Tumor sample,age: M,Sex: 67,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428729/suppl/GSM3428729_HCC_60T.CEL.gz,54675,M,HCC,Positive,60,67,Tumor sample GSM3428730,Tumor (HCC 62T),GSM3428730,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 62,disease state: HCC,tissue: Tumor sample,age: M,Sex: 66,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428730/suppl/GSM3428730_HCC_62T.CEL.gz,54675,M,HCC,Positive,62,66,Tumor sample GSM3428731,Tumor (HCC 64T),GSM3428731,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 64,disease state: HCC,tissue: Tumor sample,age: M,Sex: 67,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428731/suppl/GSM3428731_HCC_64T.CEL.gz,54675,M,HCC,Positive,64,67,Tumor sample GSM3428732,Tumor (HCC 65T),GSM3428732,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 65,disease state: HCC,tissue: Tumor sample,age: M,Sex: 76,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428732/suppl/GSM3428732_HCC_65T.CEL.gz,54675,M,HCC,Positive,65,76,Tumor sample GSM3428733,Tumor (HCC 66T),GSM3428733,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 66,disease state: HCC,tissue: Tumor sample,age: M,Sex: 50,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428733/suppl/GSM3428733_HCC_66T.CEL.gz,54675,M,HCC,Positive,66,50,Tumor sample GSM3428734,Tumor (HCC 67T),GSM3428734,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 67,disease state: HCC,tissue: Tumor sample,age: M,Sex: 30,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428734/suppl/GSM3428734_HCC_67T.CEL.gz,54675,M,HCC,Positive,67,30,Tumor sample GSM3428735,Tumor (HCC 68T),GSM3428735,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 68,disease state: HCC,tissue: Tumor sample,age: M,Sex: 54,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428735/suppl/GSM3428735_HCC_68T.CEL.gz,54675,M,HCC,Positive,68,54,Tumor sample GSM3428736,Tumor (HCC 71T),GSM3428736,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 71,disease state: HCC,tissue: Tumor sample,age: M,Sex: 33,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428736/suppl/GSM3428736_HCC_71T.CEL.gz,54675,M,HCC,Positive,71,33,Tumor sample GSM3428737,Tumor (HCC 72T),GSM3428737,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 72,disease state: HCC,tissue: Tumor sample,age: M,Sex: 61,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428737/suppl/GSM3428737_HCC_72T.CEL.gz,54675,M,HCC,Positive,72,61,Tumor sample GSM3428738,Tumor (HCC 73T),GSM3428738,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 73,disease state: HCC,tissue: Tumor sample,age: M,Sex: 51,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428738/suppl/GSM3428738_HCC_73T.CEL.gz,54675,M,HCC,Positive,73,51,Tumor sample GSM3428739,Tumor (HCC 75T),GSM3428739,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 75,disease state: HCC,tissue: Tumor sample,age: M,Sex: 38,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428739/suppl/GSM3428739_HCC_75T.CEL.gz,54675,M,HCC,Positive,75,38,Tumor sample GSM3428740,Tumor (HCC 77T),GSM3428740,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 77,disease state: HCC,tissue: Tumor sample,age: M,Sex: 79,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428740/suppl/GSM3428740_HCC_77T.CEL.gz,54675,M,HCC,Positive,77,79,Tumor sample GSM3428741,Tumor (HCC 78T),GSM3428741,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 78,disease state: HCC,tissue: Tumor sample,age: M,Sex: 68,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428741/suppl/GSM3428741_HCC_78T.CEL.gz,54675,M,HCC,Positive,78,68,Tumor sample GSM3428742,Tumor (HCC 79T),GSM3428742,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 79,disease state: HCC,tissue: Tumor sample,age: M,Sex: 59,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428742/suppl/GSM3428742_HCC_79T.CEL.gz,54675,M,HCC,Positive,79,59,Tumor sample GSM3428743,Tumor (HCC 80T),GSM3428743,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 80,disease state: HCC,tissue: Tumor sample,age: M,Sex: 72,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428743/suppl/GSM3428743_HCC_80T.CEL.gz,54675,M,HCC,Positive,80,72,Tumor sample GSM3428744,Tumor (HCC 81T),GSM3428744,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 81,disease state: HCC,tissue: Tumor sample,age: M,Sex: 57,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428744/suppl/GSM3428744_HCC_81T.CEL.gz,54675,M,HCC,Positive,81,57,Tumor sample GSM3428745,Tumor (HCC 82T),GSM3428745,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 82,disease state: HCC,tissue: Tumor sample,age: F,Sex: 52,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428745/suppl/GSM3428745_HCC_82T.CEL.gz,54675,F,HCC,Positive,82,52,Tumor sample GSM3428746,Tumor (HCC 83T),GSM3428746,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 83,disease state: HCC,tissue: Tumor sample,age: M,Sex: 57,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428746/suppl/GSM3428746_HCC_83T.CEL.gz,54675,M,HCC,Positive,83,57,Tumor sample GSM3428747,Tumor (HCC 84T),GSM3428747,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 84,disease state: HCC,tissue: Tumor sample,age: F,Sex: 35,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428747/suppl/GSM3428747_HCC_84T.CEL.gz,54675,F,HCC,Positive,84,35,Tumor sample GSM3428748,Tumor (HCC 85T),GSM3428748,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 85,disease state: HCC,tissue: Tumor sample,age: M,Sex: 57,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428748/suppl/GSM3428748_HCC_85T.CEL.gz,54675,M,HCC,Positive,85,57,Tumor sample GSM3428749,Tumor (HCC 87T),GSM3428749,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 87,disease state: HCC,tissue: Tumor sample,age: M,Sex: 33,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428749/suppl/GSM3428749_HCC_87T.CEL.gz,54675,M,HCC,Positive,87,33,Tumor sample GSM3428750,Tumor (HCC 88T),GSM3428750,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 88,disease state: HCC,tissue: Tumor sample,age: F,Sex: 60,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428750/suppl/GSM3428750_HCC_88T.CEL.gz,54675,F,HCC,Positive,88,60,Tumor sample GSM3428751,Tumor (HCC 89T),GSM3428751,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 89,disease state: HCC,tissue: Tumor sample,age: M,Sex: 69,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428751/suppl/GSM3428751_HCC_89T.CEL.gz,54675,M,HCC,Positive,89,69,Tumor sample GSM3428752,Tumor (HCC 92T),GSM3428752,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 92,disease state: HCC,tissue: Tumor sample,age: M,Sex: 48,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428752/suppl/GSM3428752_HCC_92T.CEL.gz,54675,M,HCC,Positive,92,48,Tumor sample GSM3428753,Tumor (HCC 93T),GSM3428753,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 93,disease state: HCC,tissue: Tumor sample,age: M,Sex: 75,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428753/suppl/GSM3428753_HCC_93T.CEL.gz,54675,M,HCC,Positive,93,75,Tumor sample GSM3428754,Tumor (HCC 95T),GSM3428754,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 95,disease state: HCC,tissue: Tumor sample,age: M,Sex: 66,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428754/suppl/GSM3428754_HCC_95T.CEL.gz,54675,M,HCC,Positive,95,66,Tumor sample GSM3428755,Tumor (HCC 97T),GSM3428755,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 97,disease state: HCC,tissue: Tumor sample,age: M,Sex: 59,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428755/suppl/GSM3428755_HCC_97T.CEL.gz,54675,M,HCC,Positive,97,59,Tumor sample GSM3428756,Tumor (HCC 101T),GSM3428756,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 101,disease state: HCC,tissue: Tumor sample,age: M,Sex: 44,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428756/suppl/GSM3428756_HCC_101T.CEL.gz,54675,M,HCC,Positive,101,44,Tumor sample GSM3428757,Tumor (HCC 102T),GSM3428757,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 102,disease state: HCC,tissue: Tumor sample,age: M,Sex: 66,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428757/suppl/GSM3428757_HCC_102T.CEL.gz,54675,M,HCC,Positive,102,66,Tumor sample GSM3428758,Tumor (HCC 104T),GSM3428758,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 104,disease state: HCC,tissue: Tumor sample,age: M,Sex: 83,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428758/suppl/GSM3428758_HCC_104T.CEL.gz,54675,M,HCC,Positive,104,83,Tumor sample GSM3428759,Tumor (HCC 106T),GSM3428759,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 106,disease state: HCC,tissue: Tumor sample,age: M,Sex: 64,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428759/suppl/GSM3428759_HCC_106T.CEL.gz,54675,M,HCC,Positive,106,64,Tumor sample GSM3428760,Tumor (HCC 107T),GSM3428760,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 107,disease state: HCC,tissue: Tumor sample,age: M,Sex: 62,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428760/suppl/GSM3428760_HCC_107T.CEL.gz,54675,M,HCC,Positive,107,62,Tumor sample GSM3428761,Tumor (HCC 108T),GSM3428761,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 108,disease state: HCC,tissue: Tumor sample,age: M,Sex: 73,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428761/suppl/GSM3428761_HCC_108T.CEL.gz,54675,M,HCC,Positive,108,73,Tumor sample GSM3428762,Tumor (HCC 126T),GSM3428762,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 126,disease state: HCC,tissue: Tumor sample,age: F,Sex: 72,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428762/suppl/GSM3428762_HCC_126T.CEL.gz,54675,F,HCC,Positive,126,72,Tumor sample GSM3428763,Tumor (HCC 127T),GSM3428763,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 127,disease state: HCC,tissue: Tumor sample,age: M,Sex: 39,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428763/suppl/GSM3428763_HCC_127T.CEL.gz,54675,M,HCC,Positive,127,39,Tumor sample GSM3428764,Tumor (HCC 132T),GSM3428764,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 132,disease state: HCC,tissue: Tumor sample,age: M,Sex: 69,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428764/suppl/GSM3428764_HCC_132T.CEL.gz,54675,M,HCC,Positive,132,69,Tumor sample GSM3428765,Tumor (HCC 133T),GSM3428765,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 133,disease state: HCC,tissue: Tumor sample,age: M,Sex: 35,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428765/suppl/GSM3428765_HCC_133T.CEL.gz,54675,M,HCC,Positive,133,35,Tumor sample GSM3428766,Tumor (HCC 146T),GSM3428766,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 146,disease state: HCC,tissue: Tumor sample,age: M,Sex: 62,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428766/suppl/GSM3428766_HCC_146T.CEL.gz,54675,M,HCC,Positive,146,62,Tumor sample GSM3428767,Tumor (HCC 152T),GSM3428767,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 152,disease state: HCC,tissue: Tumor sample,age: M,Sex: 59,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428767/suppl/GSM3428767_HCC_152T.CEL.gz,54675,M,HCC,Positive,152,59,Tumor sample GSM3428768,Tumor (HCC 154T),GSM3428768,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 154,disease state: HCC,tissue: Tumor sample,age: M,Sex: 64,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428768/suppl/GSM3428768_HCC_154T.CEL.gz,54675,M,HCC,Positive,154,64,Tumor sample GSM3428769,Tumor (HCC 157T),GSM3428769,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 157,disease state: HCC,tissue: Tumor sample,age: M,Sex: 70,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428769/suppl/GSM3428769_HCC_157T.CEL.gz,54675,M,HCC,Positive,157,70,Tumor sample GSM3428770,Tumor (HCC 162T),GSM3428770,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 162,disease state: HCC,tissue: Tumor sample,age: M,Sex: 62,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428770/suppl/GSM3428770_HCC_162T.CEL.gz,54675,M,HCC,Positive,162,62,Tumor sample GSM3428771,Tumor (HCC 165T),GSM3428771,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 165,disease state: HCC,tissue: Tumor sample,age: M,Sex: 56,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428771/suppl/GSM3428771_HCC_165T.CEL.gz,54675,M,HCC,Positive,165,56,Tumor sample GSM3428772,Tumor (HCC 166T),GSM3428772,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 166,disease state: HCC,tissue: Tumor sample,age: M,Sex: 81,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428772/suppl/GSM3428772_HCC_166T.CEL.gz,54675,M,HCC,Positive,166,81,Tumor sample GSM3428773,Tumor (HCC 167T),GSM3428773,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 167,disease state: HCC,tissue: Tumor sample,age: M,Sex: 77,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428773/suppl/GSM3428773_HCC_167T.CEL.gz,54675,M,HCC,Positive,167,77,Tumor sample GSM3428774,Tumor (HCC 168T),GSM3428774,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 168,disease state: HCC,tissue: Tumor sample,age: M,Sex: 72,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428774/suppl/GSM3428774_HCC_168T.CEL.gz,54675,M,HCC,Positive,168,72,Tumor sample GSM3428775,Tumor (HCC 169T),GSM3428775,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 169,disease state: HCC,tissue: Tumor sample,age: F,Sex: 74,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428775/suppl/GSM3428775_HCC_169T.CEL.gz,54675,F,HCC,Positive,169,74,Tumor sample GSM3428776,Tumor (HCC 170T),GSM3428776,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 170,disease state: HCC,tissue: Tumor sample,age: F,Sex: 72,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428776/suppl/GSM3428776_HCC_170T.CEL.gz,54675,F,HCC,Positive,170,72,Tumor sample GSM3428777,Tumor (HCC 171T),GSM3428777,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 171,disease state: HCC,tissue: Tumor sample,age: M,Sex: 64,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428777/suppl/GSM3428777_HCC_171T.CEL.gz,54675,M,HCC,Positive,171,64,Tumor sample GSM3428778,Tumor (HCC 172T),GSM3428778,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 172,disease state: HCC,tissue: Tumor sample,age: M,Sex: 75,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428778/suppl/GSM3428778_HCC_172T.CEL.gz,54675,M,HCC,Positive,172,75,Tumor sample GSM3428779,Tumor (HCC 173T),GSM3428779,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 173,disease state: HCC,tissue: Tumor sample,age: M,Sex: 51,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428779/suppl/GSM3428779_HCC_173T.CEL.gz,54675,M,HCC,Positive,173,51,Tumor sample GSM3428780,Tumor (HCC 174T),GSM3428780,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 174,disease state: HCC,tissue: Tumor sample,age: M,Sex: 56,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428780/suppl/GSM3428780_HCC_174T.CEL.gz,54675,M,HCC,Positive,174,56,Tumor sample GSM3428781,Tumor (HCC 175T),GSM3428781,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 175,disease state: HCC,tissue: Tumor sample,age: M,Sex: 80,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428781/suppl/GSM3428781_HCC_175T.CEL.gz,54675,M,HCC,Positive,175,80,Tumor sample GSM3428782,Tumor (HCC 176T),GSM3428782,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 176,disease state: HCC,tissue: Tumor sample,age: M,Sex: 55,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428782/suppl/GSM3428782_HCC_176T.CEL.gz,54675,M,HCC,Positive,176,55,Tumor sample GSM3428783,Tumor (HCC 177T),GSM3428783,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 177,disease state: HCC,tissue: Tumor sample,age: M,Sex: 52,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428783/suppl/GSM3428783_HCC_177T.CEL.gz,54675,M,HCC,Positive,177,52,Tumor sample GSM3428784,Tumor (HCC 178T),GSM3428784,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 178,disease state: HCC,tissue: Tumor sample,age: F,Sex: 76,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428784/suppl/GSM3428784_HCC_178T.CEL.gz,54675,F,HCC,Positive,178,76,Tumor sample GSM3428785,Tumor (HCC 179T),GSM3428785,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Tumor sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 179,disease state: HCC,tissue: Tumor sample,age: M,Sex: 53,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from HCC Tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428785/suppl/GSM3428785_HCC_179T.CEL.gz,54675,M,HCC,Positive,179,53,Tumor sample GSM3428786,Adjacent Normal (HCC 53N),GSM3428786,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 53,disease state: HCC,tissue: Adjacent Normal sample,age: F,Sex: 58,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428786/suppl/GSM3428786_HCC_53N.CEL.gz,54675,F,HCC,Positive,53,58,Adjacent Normal sample GSM3428787,Adjacent Normal (HCC 56N),GSM3428787,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 56,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 51,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428787/suppl/GSM3428787_HCC_56N.CEL.gz,54675,M,HCC,Positive,56,51,Adjacent Normal sample GSM3428788,Adjacent Normal (HCC 60N),GSM3428788,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 60,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 67,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428788/suppl/GSM3428788_HCC_60N.CEL.gz,54675,M,HCC,Positive,60,67,Adjacent Normal sample GSM3428789,Adjacent Normal (HCC 62N),GSM3428789,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 62,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 66,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428789/suppl/GSM3428789_HCC_62N.CEL.gz,54675,M,HCC,Positive,62,66,Adjacent Normal sample GSM3428790,Adjacent Normal (HCC 64N),GSM3428790,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 64,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 67,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428790/suppl/GSM3428790_HCC_64N.CEL.gz,54675,M,HCC,Positive,64,67,Adjacent Normal sample GSM3428791,Adjacent Normal (HCC 65N),GSM3428791,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 65,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 76,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428791/suppl/GSM3428791_HCC_65N.CEL.gz,54675,M,HCC,Positive,65,76,Adjacent Normal sample GSM3428792,Adjacent Normal (HCC 66N),GSM3428792,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 66,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 50,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428792/suppl/GSM3428792_HCC_66N.CEL.gz,54675,M,HCC,Positive,66,50,Adjacent Normal sample GSM3428793,Adjacent Normal (HCC 67N),GSM3428793,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 67,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 30,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428793/suppl/GSM3428793_HCC_67N.CEL.gz,54675,M,HCC,Positive,67,30,Adjacent Normal sample GSM3428794,Adjacent Normal (HCC 68N),GSM3428794,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 68,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 54,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428794/suppl/GSM3428794_HCC_68N.CEL.gz,54675,M,HCC,Positive,68,54,Adjacent Normal sample GSM3428795,Adjacent Normal (HCC 71N),GSM3428795,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 71,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 33,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428795/suppl/GSM3428795_HCC_71N.CEL.gz,54675,M,HCC,Positive,71,33,Adjacent Normal sample GSM3428796,Adjacent Normal (HCC 72N),GSM3428796,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 72,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 61,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428796/suppl/GSM3428796_HCC_72N.CEL.gz,54675,M,HCC,Positive,72,61,Adjacent Normal sample GSM3428797,Adjacent Normal (HCC 73N),GSM3428797,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 73,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 51,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428797/suppl/GSM3428797_HCC_73N.CEL.gz,54675,M,HCC,Positive,73,51,Adjacent Normal sample GSM3428798,Adjacent Normal (HCC 75N),GSM3428798,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 75,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 38,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428798/suppl/GSM3428798_HCC_75N.CEL.gz,54675,M,HCC,Positive,75,38,Adjacent Normal sample GSM3428799,Adjacent Normal (HCC 77N),GSM3428799,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 77,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 79,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428799/suppl/GSM3428799_HCC_77N.CEL.gz,54675,M,HCC,Positive,77,79,Adjacent Normal sample GSM3428800,Adjacent Normal (HCC 78N),GSM3428800,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 78,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 68,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428800/suppl/GSM3428800_HCC_78N.CEL.gz,54675,M,HCC,Positive,78,68,Adjacent Normal sample GSM3428801,Adjacent Normal (HCC 79N),GSM3428801,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 79,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 59,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428801/suppl/GSM3428801_HCC_79N.CEL.gz,54675,M,HCC,Positive,79,59,Adjacent Normal sample GSM3428802,Adjacent Normal (HCC 80N),GSM3428802,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 80,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 72,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428802/suppl/GSM3428802_HCC_80N.CEL.gz,54675,M,HCC,Positive,80,72,Adjacent Normal sample GSM3428803,Adjacent Normal (HCC 81N),GSM3428803,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 81,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 57,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428803/suppl/GSM3428803_HCC_81N.CEL.gz,54675,M,HCC,Positive,81,57,Adjacent Normal sample GSM3428804,Adjacent Normal (HCC 82N),GSM3428804,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 82,disease state: HCC,tissue: Adjacent Normal sample,age: F,Sex: 52,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428804/suppl/GSM3428804_HCC_82N.CEL.gz,54675,F,HCC,Positive,82,52,Adjacent Normal sample GSM3428805,Adjacent Normal (HCC 83N),GSM3428805,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 83,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 57,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428805/suppl/GSM3428805_HCC_83N.CEL.gz,54675,M,HCC,Positive,83,57,Adjacent Normal sample GSM3428806,Adjacent Normal (HCC 84N),GSM3428806,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 84,disease state: HCC,tissue: Adjacent Normal sample,age: F,Sex: 35,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428806/suppl/GSM3428806_HCC_84N.CEL.gz,54675,F,HCC,Positive,84,35,Adjacent Normal sample GSM3428807,Adjacent Normal (HCC 85N),GSM3428807,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 85,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 57,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428807/suppl/GSM3428807_HCC_85N.CEL.gz,54675,M,HCC,Positive,85,57,Adjacent Normal sample GSM3428808,Adjacent Normal (HCC 162N),GSM3428808,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 162,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 62,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428808/suppl/GSM3428808_HCC_162N.CEL.gz,54675,M,HCC,Positive,162,62,Adjacent Normal sample GSM3428809,Adjacent Normal (HCC 165N),GSM3428809,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 165,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 56,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428809/suppl/GSM3428809_HCC_165N.CEL.gz,54675,M,HCC,Positive,165,56,Adjacent Normal sample GSM3428810,Adjacent Normal (HCC 166N),GSM3428810,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 166,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 81,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428810/suppl/GSM3428810_HCC_166N.CEL.gz,54675,M,HCC,Positive,166,81,Adjacent Normal sample GSM3428811,Adjacent Normal (HCC 167N),GSM3428811,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 167,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 77,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428811/suppl/GSM3428811_HCC_167N.CEL.gz,54675,M,HCC,Positive,167,77,Adjacent Normal sample GSM3428812,Adjacent Normal (HCC 168N),GSM3428812,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 168,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 72,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428812/suppl/GSM3428812_HCC_168N.CEL.gz,54675,M,HCC,Positive,168,72,Adjacent Normal sample GSM3428813,Adjacent Normal (HCC 169N),GSM3428813,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 169,disease state: HCC,tissue: Adjacent Normal sample,age: F,Sex: 74,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428813/suppl/GSM3428813_HCC_169N.CEL.gz,54675,F,HCC,Positive,169,74,Adjacent Normal sample GSM3428814,Adjacent Normal (HCC 170N),GSM3428814,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 170,disease state: HCC,tissue: Adjacent Normal sample,age: F,Sex: 72,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428814/suppl/GSM3428814_HCC_170N.CEL.gz,54675,F,HCC,Positive,170,72,Adjacent Normal sample GSM3428815,Adjacent Normal (HCC 171N),GSM3428815,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 171,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 64,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428815/suppl/GSM3428815_HCC_171N.CEL.gz,54675,M,HCC,Positive,171,64,Adjacent Normal sample GSM3428816,Adjacent Normal (HCC 172N),GSM3428816,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 172,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 75,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428816/suppl/GSM3428816_HCC_172N.CEL.gz,54675,M,HCC,Positive,172,75,Adjacent Normal sample GSM3428817,Adjacent Normal (HCC 173N),GSM3428817,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 173,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 51,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428817/suppl/GSM3428817_HCC_173N.CEL.gz,54675,M,HCC,Positive,173,51,Adjacent Normal sample GSM3428818,Adjacent Normal (HCC 174N),GSM3428818,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 174,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 56,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428818/suppl/GSM3428818_HCC_174N.CEL.gz,54675,M,HCC,Positive,174,56,Adjacent Normal sample GSM3428819,Adjacent Normal (HCC 175N),GSM3428819,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 175,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 80,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428819/suppl/GSM3428819_HCC_175N.CEL.gz,54675,M,HCC,Positive,175,80,Adjacent Normal sample GSM3428820,Adjacent Normal (HCC 176N),GSM3428820,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 176,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 55,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428820/suppl/GSM3428820_HCC_176N.CEL.gz,54675,M,HCC,Positive,176,55,Adjacent Normal sample GSM3428821,Adjacent Normal (HCC 177N),GSM3428821,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 177,disease state: HCC,tissue: Adjacent Normal sample,age: M,Sex: 52,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428821/suppl/GSM3428821_HCC_177N.CEL.gz,54675,M,HCC,Positive,177,52,Adjacent Normal sample GSM3428822,Adjacent Normal (HCC 178N),GSM3428822,Public on Oct 16 2018,Oct 15 2018,Oct 16 2018,RNA,1,Adjacent Normal sample from hepatocellular carcinoma patient,Homo sapiens,individual id: 178,disease state: HCC,tissue: Adjacent Normal sample,age: F,Sex: 76,hbv status: Positive,The tissues were frozen immediately after collection and were stored at -80 oC.,Patients with hepatocellular carcinoma were recruited at diagnosis according to the protocol approved by the Institutional Review Board. Informed consent was obtained from all subjects before Tissue samples were collected.,total RNA,Total RNA was extracted from frozen HCC biopsies using TRIZOL Reagent following the manufacturer's protocol.,biotin,Five micrograms of total RNA were reverse-transcribed and labeled with biotin.,9606,"The final cRNA obtained was hybridized to the GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, USA).",GeneChips were scanned using the Affymetrix GeneChip Scanner 3000,Gene expression data from Adjacent Normal tissue sample of hepatocellular carcinoma patient,"The data was analysed using Partek Genomics Suite version 6.6. CEL files were imported into Partek with RMA background correction, quantile normalisation and log2 transformation.Batch effects were removed based on microarray scandate factor using Partek Batch-remove algorithm.",GPL570,"Kam,,Hui",cmrhkm@nccs.com.sg,National Cancer Centre Singapore,11 Hospital Drive,Singapore,169610,Singapore,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3428nnn/GSM3428822/suppl/GSM3428822_HCC_178N.CEL.gz,54675,F,HCC,Positive,178,76,Adjacent Normal sample